These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22142540)

  • 1. Synthesis of bivalent lactosides and their activity as sensors for differences between lectins in inter- and intrafamily comparisons.
    André S; Jarikote DV; Yan D; Vincenz L; Wang GN; Kaltner H; Murphy PV; Gabius HJ
    Bioorg Med Chem Lett; 2012 Jan; 22(1):313-8. PubMed ID: 22142540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of bivalent lactosides based on terephthalamide, N,N'-diglucosylterephthalamide, and glycophane scaffolds and assessment of their inhibitory capacity on medically relevant lectins.
    Leyden R; Velasco-Torrijos T; André S; Gouin S; Gabius HJ; Murphy PV
    J Org Chem; 2009 Dec; 74(23):9010-26. PubMed ID: 19899775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins.
    André S; Sansone F; Kaltner H; Casnati A; Kopitz J; Gabius HJ; Ungaro R
    Chembiochem; 2008 Jul; 9(10):1649-61. PubMed ID: 18509838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis.
    Rauthu SR; Shiao TC; André S; Miller MC; Madej É; Mayo KH; Gabius HJ; Roy R
    Chembiochem; 2015 Jan; 16(1):126-39. PubMed ID: 25407851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside.
    André S; Liu B; Gabius HJ; Roy R
    Org Biomol Chem; 2003 Nov; 1(22):3909-16. PubMed ID: 14664382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bi- to tetravalent glycoclusters: synthesis, structure-activity profiles as lectin inhibitors and impact of combining both valency and headgroup tailoring on selectivity.
    Wang GN; André S; Gabius HJ; Murphy PV
    Org Biomol Chem; 2012 Sep; 10(34):6893-907. PubMed ID: 22842468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets.
    André S; Kaltner H; Furuike T; Nishimura S; Gabius HJ
    Bioconjug Chem; 2004; 15(1):87-98. PubMed ID: 14733587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
    Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
    Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity-structure correlations in divergent lectin evolution: fine specificity of chicken galectin CG-14 and computational analysis of flexible ligand docking for CG-14 and the closely related CG-16.
    Wu AM; Singh T; Liu JH; Krzeminski M; Russwurm R; Siebert HC; Bonvin AM; André S; Gabius HJ
    Glycobiology; 2007 Feb; 17(2):165-84. PubMed ID: 17060369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-tuning of prototype chicken galectins: structure of CG-2 and structure-activity correlations.
    Ruiz FM; Fernández IS; López-Merino L; Lagartera L; Kaltner H; Menéndez M; André S; Solís D; Gabius HJ; Romero A
    Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1665-76. PubMed ID: 23999290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin-based drug design: combined strategy to identify lead compounds using STD NMR spectroscopy, solid-phase assays and cell binding for a plant toxin model.
    Ribeiro JP; André S; Cañada FJ; Gabius HJ; Butera AP; Alves RJ; Jiménez-Barbero J
    ChemMedChem; 2010 Mar; 5(3):415-9, 314. PubMed ID: 20094999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory potential of chemical substitutions at bioinspired sites of β-D-galactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins.
    Giguère D; André S; Bonin MA; Bellefleur MA; Provencal A; Cloutier P; Pucci B; Roy R; Gabius HJ
    Bioorg Med Chem; 2011 May; 19(10):3280-7. PubMed ID: 21524586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teaming up synthetic chemistry and histochemistry for activity screening in galectin-directed inhibitor design.
    Roy R; Cao Y; Kaltner H; Kottari N; Shiao TC; Belkhadem K; André S; Manning JC; Murphy PV; Gabius HJ
    Histochem Cell Biol; 2017 Feb; 147(2):285-301. PubMed ID: 28013366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bi- to tetravalent glycoclusters presenting GlcNAc/GalNAc as inhibitors: from plant agglutinins to human macrophage galactose-type lectin (CD301) and galectins.
    André S; O'Sullivan S; Koller C; Murphy PV; Gabius HJ
    Org Biomol Chem; 2015 Apr; 13(14):4190-203. PubMed ID: 25721929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase synthesis for the identification of high-affinity bivalent lectin ligands.
    Debenham SD; Snyder PW; Toone EJ
    J Org Chem; 2003 Jul; 68(15):5805-11. PubMed ID: 12868911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetric dithiodigalactoside: strategic combination of binding studies and detection of selectivity between a plant toxin and human lectins.
    Martín-Santamaría S; André S; Buzamet E; Caraballo R; Fernández-Cureses G; Morando M; Ribeiro JP; Ramírez-Gualito K; de Pascual-Teresa B; Cañada FJ; Menéndez M; Ramström O; Jiménez-Barbero J; Solís D; Gabius HJ
    Org Biomol Chem; 2011 Aug; 9(15):5445-55. PubMed ID: 21660340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward bioinspired galectin mimetics: identification of ligand-contacting peptides by proteolytic-excision mass spectrometry.
    Moise A; André S; Eggers F; Krzeminski M; Przybylski M; Gabius HJ
    J Am Chem Soc; 2011 Sep; 133(38):14844-7. PubMed ID: 21861497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining carbohydrate substitutions at bioinspired positions with multivalent presentation towards optimising lectin inhibitors: case study with calixarenes.
    André S; Grandjean C; Gautier FM; Bernardi S; Sansone F; Gabius HJ; Ungaro R
    Chem Commun (Camb); 2011 Jun; 47(21):6126-8. PubMed ID: 21523264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells.
    André S; Lahmann M; Gabius HJ; Oscarson S
    Mol Pharm; 2010 Dec; 7(6):2270-9. PubMed ID: 21028902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of triazole-tethered glycoclusters exhibiting three different spatial arrangements and comparative study of their affinities towards PA-IL and RCA 120 by using a dna-based glycoarray.
    Moni L; Pourceau G; Zhang J; Meyer A; Vidal S; Souteyrand E; Dondoni A; Morvan F; Chevolot Y; Vasseur JJ; Marra A
    Chembiochem; 2009 May; 10(8):1369-78. PubMed ID: 19405074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.